𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐌𝐢𝐜𝐞 𝐌𝐨𝐝𝐞𝐥𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐕𝐚𝐥𝐮𝐞 𝐭𝐨 𝐇𝐢𝐭 𝐔𝐒$ 𝟔𝟗𝟔.𝟒 𝐌𝐧 𝐢𝐧 𝟐𝟎𝟑𝟐 | 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬- 𝐓

𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐌𝐢𝐜𝐞 𝐌𝐨𝐝𝐞𝐥𝐬 𝐌𝐚𝐫𝐤𝐞𝐭

𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐨𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐦𝐢𝐜𝐞 𝐦𝐨𝐝𝐞𝐥𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒$ 𝟑𝟕𝟎.𝟗 𝐌𝐧 𝐢𝐧 𝟐𝟎𝟐𝟏 and is set to expand 1.8X over the next ten years. 𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐦𝐚𝐫𝐤𝐞𝐭 𝐟𝐨𝐫 𝐨𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐦𝐢𝐜𝐞 𝐦𝐨𝐝𝐞𝐥𝐬 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒$ 𝟔𝟗𝟔.𝟒 𝐌𝐧 𝐛𝐲 𝐭𝐡𝐞 𝐞𝐧𝐝 𝐨𝐟 𝟐𝟎𝟑𝟐. Rising development of new immuno-oncology drugs and therapies, demand for immuno-oncology for cancer treatment, and development of combination IO therapies will drive market expansion. 

North America currently holds the largest market share of around 48.6%. The Germany oncology mice models market is expected to exhibit healthy growth at 6.5% CAGR during the forecast period. 

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭@ https://www.persistencemarketresearch.com/samples/33046

Cancer immunotherapy, also known as immuno-oncology, is a type of cancer treatment that utilizes the immune system's ability to inhibit, control, and eliminate cancer. Immunotherapy educates the immune system to recognize and attack specific cancer cells. Immunotherapy also boosts the immune cells by providing additional components to a body to help them eliminate cancer.

Despite continuous improvement and identification of novel cancer immunotherapy, there is a pressing need to establish a robust platform to evaluate the efficacy and safety of pre-clinical drugs, simulate the interaction between patients' tumor and immune systems, and predict patients' responses to the treatment. Immuno-oncology therapies work by taking breaks off the immune system or boosting its ability to detect and destroy tumor cells.

Most pharma companies are focusing on the production of next-generation combination IO therapies. In recent years, a large number of immuno-oncology drugs were developed by various pharma companies, which can boost the growth of this market.

𝐊𝐞𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬- 

• 𝐓𝐡𝐞 𝐉𝐚𝐜𝐤𝐬𝐨𝐧 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐲
• 𝐓𝐚𝐜𝐨𝐧𝐢𝐜 𝐁𝐢𝐨𝐬𝐜𝐢𝐞𝐧𝐜𝐞𝐬
• 𝐂𝐡𝐚𝐫𝐥𝐞𝐬 𝐑𝐢𝐯𝐞𝐫 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐢𝐞𝐬
• 𝐒𝐡𝐚𝐧𝐠𝐡𝐚𝐢 𝐌𝐨𝐝𝐞𝐥 𝐎𝐫𝐠𝐚𝐧𝐢𝐬𝐦𝐬 𝐂𝐞𝐧𝐭𝐞𝐫 𝐈𝐧𝐜.
• 𝐄𝐧𝐯𝐢𝐠𝐨
• 𝐁𝐢𝐨𝐜𝐲𝐭𝐨𝐠𝐞𝐧
• 𝐆𝐞𝐧𝐨𝐰𝐚𝐲
• 𝐂𝐫𝐨𝐰𝐧 𝐁𝐢𝐨𝐬𝐜𝐢𝐞𝐧𝐜𝐞 𝐈𝐧𝐜. (𝐉𝐒𝐑 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐢𝐨𝐧).
• 𝐂𝐲𝐚𝐠𝐞𝐧
• 𝐀𝐩𝐩𝐥𝐢𝐞𝐝 𝐬𝐭𝐞𝐦 𝐜𝐞𝐥𝐥𝐬
• 𝐈𝐧𝐠𝐞𝐧𝐢𝐨𝐮𝐬 𝐓𝐚𝐫𝐠𝐞𝐭𝐢𝐧𝐠 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐲
• 𝐏𝐨𝐥𝐲𝐆𝐞𝐧𝐞 - 𝐓𝐫𝐚𝐧𝐬𝐠𝐞𝐧𝐢𝐜 𝐦𝐢𝐜𝐞 𝐦𝐨𝐝𝐞𝐥 𝐜𝐨𝐦𝐩𝐚𝐧𝐲
• 𝐂𝐫𝐞𝐚𝐭𝐢𝐯𝐞 𝐁𝐢𝐨𝐥𝐚𝐛𝐬
• 𝐓𝐫𝐚𝐧𝐬𝐂𝐮𝐫𝐞 𝐁𝐢𝐨𝐬𝐞𝐫𝐯𝐢𝐜𝐞𝐬
• 𝐂𝐡𝐚𝐦𝐩𝐢𝐨𝐧𝐬 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐈𝐧𝐜
• 𝐂𝐞𝐫𝐭𝐢𝐬 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲
• 𝐒𝐢𝐠𝐧𝐚𝐭𝐮𝐫𝐞
• 𝐏𝐡𝐚𝐫𝐦𝐚𝐫𝐨𝐧
• 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐲 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐇𝐨𝐥𝐝𝐢𝐧𝐠𝐬
• 𝐆𝐞𝐦𝐩𝐡𝐚𝐫𝐦𝐚𝐭𝐞𝐜𝐡
• 𝐉𝐚𝐧𝐯𝐢𝐞𝐫 𝐋𝐚𝐛𝐬
• 𝐇𝐚𝐫𝐛𝐨𝐮𝐫 𝐁𝐢𝐨𝐌𝐞𝐝

𝐆𝐞𝐭 𝐅𝐮𝐥𝐥 𝐀𝐜𝐜𝐞𝐬𝐬 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐧𝐝 𝐆𝐞𝐭 𝐔𝐩 𝐭𝐨 𝟐𝟎% 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭@ https://www.persistencemarketresearch.com/checkout/33046

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲

• Syngeneic tumor mice models contributed the highest revenue share of 56.2% in 2021 in the global market.
• The end user segment was dominated by contract research organizations with nearly 1/3 revenue share in 2021.
• North America led the global market with nearly 48.6% value share in 2021.

"The global oncology mice models market is expected to witness significant growth due to development of immuno-oncology combination drugs therapy," says a Persistence Market Research analyst.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐨𝐧

Some of the leading suppliers of mice models are The Jackson Laboratory, Charles River, Taconic Biosciences, Shanghai Model organism, and Envigo amongst others. Key market players are focusing on acquisitions, collaborations, and product launches to increase their revenues across geographies.

• In February 2021, Charles River acquired Cognate Bioservices to expand its cell and gene therapy programs.
• In January 2022, Taconic Biosciences announced the launch of the huNOG-EXL EA (Early Access) humanized immune system (HIS) mouse.
• In October 2021, The Jackson Laboratory announced the acquisition of Charles River Laboratories Japan.
• In September 2021, Envigo announced a collaboration with Biocytogen to distribute the B-NDG triple immunodeficient and humanizable mouse model.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐌𝐞𝐭𝐡𝐨𝐝𝐨𝐥𝐨𝐠𝐲@
https://www.persistencemarketresearch.com/methodology/33046

Key Questions Answered in This Report -

• What is the Current Valuation of the 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐌𝐢𝐜𝐞 𝐌𝐨𝐝𝐞𝐥𝐬 Market?
• What is the CAGR of the 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐌𝐢𝐜𝐞 𝐌𝐨𝐝𝐞𝐥𝐬 Market during the Forecast Period?
• What is the Anticipated Size of the 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐌𝐢𝐜𝐞 𝐌𝐨𝐝𝐞𝐥𝐬 Market in 2032?
• What Region is Most Lucrative for 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐌𝐢𝐜𝐞 𝐌𝐨𝐝𝐞𝐥𝐬 market?
• Which Segment is the Highest Contributor in the 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐌𝐢𝐜𝐞 𝐌𝐨𝐝𝐞𝐥𝐬 market?

About us: -

Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on "micros" by Persistence Market Research helps companies overcome their "macro" business challenges.

Contact Us:

Persistence market research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

This release was published on openPR.